First-Trimester Angiopoietin-2: Relationships with Maternal and Placental Characteristics

ABSTRACT

Angiopoietin-2 (Ang-2), synthesized by endothelial cells, is a marker of placental vascular remodeling. Ang-2 is expressed in the first trimester, and levels may therefore correlate to other parameters of placental vascular development. The aim of this study was to evaluate the relationships between Ang-2 and other maternal/placental factors in the first trimester. This was a prospective observational study of women presenting for first-trimester screening at 11 + 0 to 13 + 6 weeks. Consenting women underwent an ultrasound, physical examination, and blood draw. Maternal serum Ang-2 levels were determined using enzyme-linked immunosorbent assay. Results were evaluated with relation to maternal age, parity, race, body mass index (BMI), mean arterial pressure (MAP), smoking/caffeine use, and parameters of placental blood flow resistance. In 111 consecutive patients, serum Ang-2 ranged from 0.6 to 10.9 ng/mL. Ang-2 levels were unrelated to maternal age, race, parity, smoking, and caffeine intake. Significant negative correlations were observed with BMI (Pearson's r = −0.325; p < 0.0001) and MAP (Pearson's r = −0.287; p = 0.002). Ang-2 levels did not correlate with gestational age (Spearman's rho, 0.064; p = 0.5058), but a significant positive correlation with the crown-rump length was observed (Spearman's rho, 0.261; p = 0.006). Neither uterine artery notching nor umbilical artery Doppler parameters correlated with Ang-2 levels. We concluded that Ang-2 as a marker of placental angiogenesis has significant relationships with maternal risk factors associated with abnormal placental development.

KEYWORDS

Angiopoietin-2 - first trimester - placental development - Doppler

REFERENCES

• 1 Maternal adaptations to pregnancy. In: Cunningham FG, Gant NF, Leveno KJ, Gilstrap LC, Hauth JC, Wenstrom KD Williams Obstetrics. New York, NY; McGraw-Hill 2001: 167-200
• 2 Kingdom J, Huppertz B, Seaward G, Kaufmann P. Development of the placental villous tree and its consequences for fetal growth.  Eur J Obstet Gynecol Reprod Biol. 2000;  92(1) 35-43
• 3 Kaufmann P, Mayhew T M, Charnock-Jones D S. Aspects of human fetoplacental vasculogenesis and angiogenesis. II. Changes during normal pregnancy.  Placenta. 2004;  25(2-3) 114-126
• 4 Guzin K, Tomruk S, Tuncay Y A et al.. The relation of increased uterine artery blood flow resistance and impaired trophoblast invasion in pre-eclamptic pregnancies.  Arch Gynecol Obstet. 2005;  272(4) 283-288
• 5 Papageorghiou A T, Yu C K, Erasmus I E, Cuckle H S, Nicolaides K H. Assessment of risk for the development of pre-eclampsia by maternal characteristics and uterine artery Doppler.  BJOG. 2005;  112(6) 703-709
• 6 Poon L C, Kametas N A, Pandeva I, Valencia C, Nicolaides K H. Mean arterial pressure at 11(+0) to 13(+6) weeks in the prediction of preeclampsia.  Hypertension. 2008;  51(4) 1027-1033
• 7 Hirokoshi K, Maeshima Y, Kobayashi K et al.. Increase of serum angiopoietin-2 during pregnancy is suppressed in women with preeclampsia.  Am J Hypertens. 2005;  18(9 Pt 1) 1181-1188
• 8 Wang Y, Tasevski V, Wallace E M, Gallery E D, Morris J M. Reduced maternal serum concentrations of angiopoietin-2 in the first trimester precede intrauterine growth restriction associated with placental insufficiency.  BJOG. 2007;  114(11) 1427-1431
• 9 Nicolaides K H. First-trimester screening for chromosomal abnormalities.  Semin Perinatol. 2005;  29(4) 190-194
• 10 Campbell S, Platt L. The publishing of papers on first-trimester Doppler.  Ultrasound Obstet Gynecol. 1999;  14(3) 159-160
• 11 Bukowski R, Smith G, Malone F et al.. Fetal growth in early pregnancy and risk of delivering low birth weight infant: prospective cohort study.  BMJ. 2007;  334 836